The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies
Open accessAbstract
BACKGROUND: Snakebite in India causes the highest annual rates of death (46,000) and disability (140,000) than any other country. Antivenom is the mainstay treatment of snakebite, whose manufacturing protocols, in essence, have remained unchanged for over a century. In India, a polyvalent antivenom is produced for the treatment of envenomations from the so called 'big four' snakes: the spectacled cobra (Naja naja), common krait (Bungarus caeruleus), Russell's viper (Daboia russelii), and saw-scaled viper (Echis carinatus). In addition to the 'big four', India is abode to many other species of venomous snakes that have the potential to inflict severe clinical or, even, lethal envenomations in their human bite victims. Unfortunately, specific antivenoms are not produced against these species and, instead, the 'big four' antivenom is routinely used for the treatment. METHODS: We characterized the venom compositions, biochemical and pharmacological activities and toxicity profiles (mouse model) of the major neglected yet medically important Indian snakes (E. c. sochureki, B. sindanus, B. fasciatus, and two populations of N. kaouthia) and their closest 'big four' congeners. By performing WHO recommended in vitro and in vivo preclinical assays, we evaluated the efficiencies of the commercially marketed Indian antivenoms in recognizing venoms and neutralizing envenomations by these neglected species. FINDINGS: As a consequence of dissimilar ecologies and diet, the medically important snakes investigated exhibited dramatic inter- and intraspecific differences in their venom profiles. Currently marketed antivenoms were found to exhibit poor dose efficacy and venom recognition potential against the 'neglected many'. Premium Serums antivenom failed to neutralise bites from many of the neglected species and one of the 'big four' snakes (North Indian population of B. caeruleus). CONCLUSIONS: This study unravels disturbing deficiencies in dose efficacy and neutralisation capabilities of the currently marketed Indian antivenoms, and emphasises the pressing need to develop region-specific snakebite therapy for the 'neglected many'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development
Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C. (2017) · BioMed Research International · doi:10.1155/2017/6592820 · Cited by 113 · cited 1×
“While the mechanism of action of some of the snake venom toxins have been extensively studied [70, 79, 80], others, especially the least abundant toxins, remain chiefly underinvestigated.”
Background
Cited by
Causes and Consequences of Snake Venom Variation
Casewell, N. R., Jackson, T. N. W., Laustsen, A. H., & Sunagar, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.05.006 · Cited by 396
Self-citationTrends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study
Suraweera, W., Warrell, D., Whitaker, R., Menon, G., Rodrigues, R., Fu, S. H., Begum, R., Sati, P., Piyasena, K., Bhatia, M., et al. (2020) · eLife · doi:10.7554/elife.54076 · Cited by 305
Self-citationThe chemistry of snake venom and its medicinal potential
Oliveira, A. L., Viegas, M. F., da Silva, S. L., Soares, A. M., Ramos, M. J., & Fernandes, P. A. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00393-7 · Cited by 289
Senji Laxme, R. R., Attarde, S., Khochare, S., Suranse, V., Martin, G., Casewell, N. R., Whitaker, R., & Sunagar, K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009150 · Cited by 101
Self-citationSenji Laxme, R. R., Khochare, S., Attarde, S., Suranse, V., Iyer, A., Casewell, N. R., Whitaker, R., Martin, G., & Sunagar, K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009247 · Cited by 101
Self-citation
Metadata
- Authors
- Senji Laxme, R. R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-12-05
- Volume
- 13
- Issue
- 12
- Pages
- e0007899
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2992890331
- Cited by
- 195
- References
- 1
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies. https://app.cochat.ai/papers/10.1371/journal.pntd.0007899
- The paper
- Senji Laxme, R. R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K. (2019). Beyond the ‘big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0007899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.